Skip to main content
. 2016 Nov 30;514(1):229–237. doi: 10.1016/j.ijpharm.2016.07.002

Fig. 1.

Fig. 1

Phase solubility diagrams of thalidomide in presence of (a) β-CD, (b) HP-β-CD and (c) SBE-β-CD (mean values ± S.D.; n = 3). Linear fitting: (a) y = 0.16626 + 0.04830 x (R2 = 0.99), (b) y = 0.19209 + 0.01669 x (R2 = 0.99) and (c) y = 0.19313 + 0.03153 x (R2 = 0.97).